Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2).
von Hagens C, Walter-Sack I, Goeckenjan M, Storch-Hagenlocher B, Sertel S, Elsässer M, Remppis BA, Munzinger J, Edler L, Efferth T, Schneeweiss A, Strowitzki T. von Hagens C, et al. Among authors: storch hagenlocher b. Phytomedicine. 2019 Feb 15;54:140-148. doi: 10.1016/j.phymed.2018.09.178. Epub 2018 Sep 17. Phytomedicine. 2019. PMID: 30668363 Clinical Trial.
Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2).
von Hagens C, Walter-Sack I, Goeckenjan M, Osburg J, Storch-Hagenlocher B, Sertel S, Elsässer M, Remppis BA, Edler L, Munzinger J, Efferth T, Schneeweiss A, Strowitzki T. von Hagens C, et al. Among authors: storch hagenlocher b. Breast Cancer Res Treat. 2017 Jul;164(2):359-369. doi: 10.1007/s10549-017-4261-1. Epub 2017 Apr 24. Breast Cancer Res Treat. 2017. PMID: 28439738 Clinical Trial.
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; CONFIRM study investigators. Miller DH, et al. Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360. Epub 2015 Feb 13. Neurology. 2015. PMID: 25681448 Free PMC article. Clinical Trial.
Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial.
Mackensen F, Jakob E, Springer C, Dobner BC, Wiehler U, Weimer P, Rohrschneider K, Fiehn C, Max R, Storch-Hagenlocher B, Becker MD. Mackensen F, et al. Among authors: storch hagenlocher b. Am J Ophthalmol. 2013 Sep;156(3):478-486.e1. doi: 10.1016/j.ajo.2013.05.002. Epub 2013 Jun 17. Am J Ophthalmol. 2013. PMID: 23786783 Clinical Trial.
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators. Fox RJ, et al. N Engl J Med. 2012 Sep 20;367(12):1087-97. doi: 10.1056/NEJMoa1206328. N Engl J Med. 2012. PMID: 22992072 Free article. Clinical Trial.
Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myeloma.
Schmitt S, Goldschmidt H, Storch-Hagenlocher B, Pham M, Fingerle-Rowson G, Ho AD, Neben K. Schmitt S, et al. Among authors: storch hagenlocher b. Int J Hematol. 2011 Jun;93(6):791-794. doi: 10.1007/s12185-011-0847-2. Epub 2011 May 7. Int J Hematol. 2011. PMID: 21553020
An unusual case of optic neuritis.
Doegel D, Mueller W, Deckert M, Lenhard T, Schmidt-Bacher A, Storch-Hagenlocher B, Biller A, Wildemann B. Doegel D, et al. Among authors: storch hagenlocher b. J Neurol Sci. 2011 May 15;304(1-2):138-41. doi: 10.1016/j.jns.2011.02.007. Epub 2011 Mar 12. J Neurol Sci. 2011. PMID: 21397912
Rippling muscle disease: variable phenotype in a family with five afflicted members.
Jacobi C, Ruscheweyh R, Vorgerd M, Weber MA, Storch-Hagenlocher B, Meinck HM. Jacobi C, et al. Among authors: storch hagenlocher b. Muscle Nerve. 2010 Jan;41(1):128-32. doi: 10.1002/mus.21446. Muscle Nerve. 2010. PMID: 19697367
[Intravenous immunoglobulins in multiple sclerosis. An update].
Schwarz S, Meinck HM, Storch-Hagenlocher B. Schwarz S, et al. Among authors: storch hagenlocher b. Nervenarzt. 2009 Aug;80(8):918-28. doi: 10.1007/s00115-009-2669-5. Nervenarzt. 2009. PMID: 19662451 Review. German.
Fulminant onset of cerebral immunocomplex vasculitis as first manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE).
Rizos T, Siegelin M, Hähnel S, Storch-Hagenlocher B, Hug A. Rizos T, et al. Among authors: storch hagenlocher b. Lupus. 2009 Apr;18(4):361-3. doi: 10.1177/0961203308097448. Lupus. 2009. PMID: 19276305
48 results
Jump to page
Feedback